Ben Auspitz

Ben Auspitz has extensive experience in the biotechnology and pharmaceutical industry. Ben is currently the Chief Executive Officer and Founder of IDRx, a position they have held since October 2021. Prior to this, Ben served as a Partner at FPrime Capital Partners for over 15 years, from November 2005 to August 2021.

Before joining FPrime Capital Partners, Ben held various leadership positions in the industry. Ben served as the Chairman of the Board at Modis Therapeutics from October 2018 to August 2019. From February 2015 to October 2018, Ben was the Chairman of the Board and Founder of Orchard Therapeutics. Ben also held the same positions at Dimension Therapeutics from October 2013 to October 2015.

Ben's earlier experience includes being a Director at Ultragenyx Pharmaceutical Inc. from May 2011 to January 2014. Ben was also a Therapeutic Area Director at CombinatoRx from 2001 to 2005. Prior to this, Ben worked as a consultant at Braun Consulting from 1999 to 2000 and Vertex Partners from 1995 to 1997.

Overall, Ben Auspitz has a strong background in leadership and executive roles within the biotechnology and pharmaceutical industry, with a focus on strategic development and growth of companies.

Ben Auspitz has attended Harvard University and UCLA, but no specific information about the degree, field of study, or duration of enrollment is provided.